№ 157 · biology

An allergy is friendly fire

An allergy is your immune system attacking something harmless. Parker and colleagues describe the sequence: a first exposure primes mast cells with IgE antibody, and a later exposure makes those cells dump histamine and other mediators within minutes. The surprise is that the same IgE machinery may also help defend against worms and venoms.

What an allergy is

Parker and colleagues classify allergy as a type I hypersensitivity. A harmless antigen — pollen, dander, mold — is called an allergen. In a susceptible person the first contact drives T helper 2 cells to release IL-4 and IL-13, which push B cells to switch from IgM to IgE. The IgE tail, the Fc region, docks on mast cells. Parker and colleagues cite an estimate that one mast cell can hold up to 500,000 IgE molecules.

Primed, then fired

On that first exposure the allergen is usually gone before IgE is ready, so nothing happens. The cell is merely sensitized. On a later contact, allergen molecules bridge several IgE antibodies at once. Parker and colleagues call this cross-linking; it triggers degranulation, the release of granule contents. Histamine, serotonin and bradykinin come out first, then newly made leukotrienes and prostaglandins. Histamine drives mucus, tears, itching and sneezing; other mediators cause hives, swelling and narrowed bronchioles. Vitte and colleagues note the mediators appear within minutes, with lipid mediators following within about 15 minutes.

Predict first

In peanut allergy, are the peanut proteins that bind the most IgE also the ones behind most of the reaction?

Check your answer

Not necessarily. Hazebrouck, Canon and Dreskin report that four peanut proteins bind a lot of IgE, yet in functional tests two of them, Ara h 2 and Ara h 6, supply 70–90% of the effector activity.

Not every allergen fires equally

Hazebrouck, Canon and Dreskin separate sensitizing from eliciting. A protein that generates IgE may not be the one that triggers the reaction. For peanut, they report that two proteins, Ara h 2 and Ara h 6, supply 70–90% of the effector activity, even though other peanut proteins bind plenty of IgE. Effector strength depends on how much specific IgE is present, the ratio of specific to total IgE, receptor numbers on the cell, antibody affinity, and the spacing of IgE-binding sites on the allergen.

Why the machinery might exist

Parker and colleagues reason that a harmful inherited trait would be expected to fade under selection, so type I reactions may have an adaptive role. They cite evidence that the IgE made in these reactions is meant to counter helminths, which are parasitic worms, and that helminth infection early in life lowers the chance of these reactions later. Allergies, they suggest, may be an unfortunate side effect of strong selection for defense against worms. Vitte and colleagues list beneficial roles for IgE-driven reactions against parasites, venoms and toxins, and credit the wider Th2 response with helping repair injured tissue. They also note mast cell proteases can degrade venom peptides. Vitte and colleagues, writing in 2022, put the share of people with allergies at up to 30% in Western countries.

Interactive Set how many IgE antibodies on the mast cell are specific for the allergen, then add allergen and see how many get bridged.

Schematic, not to scale. The cell holds 40 IgE slots, an illustrative number; the slider sets how many are specific for the allergen. Adding allergen bridges specific antibodies in pairs. The bridged count and the illustrative threshold of 2 bridged pairs are drawn from the page's model, not from a measured value in the sources; Parker and colleagues describe cross-linking as the trigger but give no threshold.

It is not only IgE

Vitte and colleagues stress that IgE is not the whole story. IgG can drive reactions to some drugs when both antibody and allergen are at high concentration, acting through neutrophils and platelets and releasing platelet-activating factor rather than histamine. Complement fragments C3a and C5a can make rat mast cells release histamine, though whether C5a does so in human mast cells is somewhat disputed. A receptor called MRGPRX2 lets mast cells respond to many basic compounds without any IgE. The authors noted in 2022 that a tryptase test cannot separate an IgE-driven reaction from one driven through MRGPRX2.

In short

The reaction is real immune output aimed at a target that poses no threat. IgE arms mast cells, cross-linking fires them, and the same system appears to do useful work against worms and venoms.

Where this comes from

  1. Microbiology, 19.1 Hypersensitivities (OpenStax) linked only, not reproduced
    Parker, Schneegurt, Tu, Lister, Forster · 2016
    openstax.org/books/microbiology/pages/19-1-hypersensitivities
  2. Allergy, Anaphylaxis, and Nonallergic Hypersensitivity: IgE, Mast Cells, and Beyond (Med Princ Pract 31(6):501-515) linked only, not reproduced
    Vitte, Vibhushan, Bratti, Montero-Hernandez, Blank · 2022
    pmc.ncbi.nlm.nih.gov/articles/PMC9841766/
  3. The Effector Function of Allergens (Front. Allergy 3:818732) linked only, not reproduced
    Hazebrouck, Canon, Dreskin · 2022
    www.frontiersin.org/journals/allergy/articles/10.3389/falgy.2022.818732/full